Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Muscle-specific ER-associated degradation maintains postnatal muscle hypertrophy and systemic energy metabolism
Benedict Abdon, Yusheng Liang, Débora da Luz Scheffer, Mauricio Torres, Neha Shrestha, Rachel B. Reinert, You Lu, Brent Pederson, Amara Bugarin-Lapuz, Sander Kersten, Ling Qi
Benedict Abdon, Yusheng Liang, Débora da Luz Scheffer, Mauricio Torres, Neha Shrestha, Rachel B. Reinert, You Lu, Brent Pederson, Amara Bugarin-Lapuz, Sander Kersten, Ling Qi
View: Text | PDF
Research Article Cell biology Muscle biology

Muscle-specific ER-associated degradation maintains postnatal muscle hypertrophy and systemic energy metabolism

  • Text
  • PDF
Abstract

The growth of skeletal muscle relies on a delicate equilibrium between protein synthesis and degradation; however, how proteostasis is managed in the endoplasmic reticulum (ER) is largely unknown. Here, we report that the SEL1L-HRD1 ER-associated degradation (ERAD) complex, the primary molecular machinery that degrades misfolded proteins in the ER, is vital to maintain postnatal muscle growth and systemic energy balance. Myocyte-specific SEL1L deletion blunts the hypertrophic phase of muscle growth, resulting in a net zero gain of muscle mass during this developmental period and a 30% reduction in overall body growth. In addition, myocyte-specific SEL1L deletion triggered a systemic reprogramming of metabolism characterized by improved glucose sensitivity, enhanced beigeing of adipocytes, and resistance to diet-induced obesity. These effects were partially mediated by the upregulation of the myokine FGF21. These findings highlight the pivotal role of SEL1L-HRD1 ERAD activity in skeletal myocytes for postnatal muscle growth, and its physiological integration in maintaining whole-body energy balance.

Authors

Benedict Abdon, Yusheng Liang, Débora da Luz Scheffer, Mauricio Torres, Neha Shrestha, Rachel B. Reinert, You Lu, Brent Pederson, Amara Bugarin-Lapuz, Sander Kersten, Ling Qi

×

Figure 8

FGF21 links SEL1L-HRD1 ERAD in skeletal muscle to systemic metabolic regulation.

Options: View larger image (or click on image) Download as PowerPoint
FGF21 links SEL1L-HRD1 ERAD in skeletal muscle to systemic metabolic reg...
(A) Representative Western blot of ER homeostasis proteins and FGF21 in WT, Sel1LMLC (SKO), FGF21MLC (FKO), and Sel1L/Fgf21 double knockout (DKO) mice (n = 4 mice per genotype). (B) Serum measurement of FGF21 from male and female mice at 16–20 weeks old (n = 5–7 per genotype). (C) Body length of 16-week-old mice (n = 7–20 for males, n = 7–14 for females). (D) Weekly body mass of male and female mice (n = 6–44 per genotype/time point for males, n = 5–45 per genotype/time point for females). Statistical comparison made between Sel1LMLC and DKO mice. (E) Muscle mass–to–body mass ratios in male mice (n = 4–18 per genotype). Comparisons were made between indicated groups. FKO muscle was not statistically different from WT. (F) Representative H&E-stained images of inguinal white adipose tissue (n = 3 mice per genotype). (G) Representative Western blot of UCP1 in WT, Sel1LMLC, FGF21MLC, and DKO mice (n = 4 mice per genotype). Data presented as mean ± SEM. NS, P > 0.05; *P < 0.05; **P < 0.01; ****P < 0.0001 determined by 1-way ANOVA with Tukey’s multiple-comparison test (B, C, and E) or mixed-effects analysis (repeated-measure ANOVA) with Tukey’s multiple-comparison test (D).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts